News

LATEST NEWS

Free Trial Lyme Kit Evaluation Program
March 18th, 2014

Lyme++

Be double positive when using the new ZEUS ELISA™ Borrelia VlsE1/pepC10 IgG/IgM Test System.

Go to www.zeusscientific.com/lyme  to sign up for our free trial evaluation program for qualified...

ZEUS Scientific Appoints Corporate Counsel
July 24th, 2013

ZEUS Scientific, a leading in vitro diagnostic solution provider, is pleased to announce the appointment of Wilentz, Goldman & Spitzer P.A. as its corporate counsel. Founded in 1919 by David T....

ZEUS Scientific Announces Formation of Corporate Board
June 22nd, 2013

ZEUS Scientific is pleased to announce the formation of a corporate board and the appointment of John Moore, W. Barry McDonald and Tim Rothwell to this board. The mandate of this board is to counsel...

University of Surrey licenses the patented use of EN2 protein as a diagnostic biomarker for prostate and bladder cancer to ZEUS Scientific
March 13th, 2013

The University of Surrey, one of the UK's leading professional, scientific and technological universities and ZEUS Scientific, a United States based global in vitro diagnostics company, announced...

Aterovax Licenses Secreted Phospholipase A2 Cardiovascular Disease Risk Test to ZEUS Scientific
November 19th, 2012

Aterovax SA, a private French diagnostics company focused on the development and commercialization of novel cardiovascular diagnostics and ZEUS Scientific, a United States based global in vitro...

ZEUS Scientific Announces FDA Clearance for ZEUS ELISA™ Borrelia VlsE1/pepC10 IgG/IgM Test System
September 4th, 2012

ZEUS Scientific announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA™ Borrelia VlsE1/pepC10 IgG/IgM Test System, product code 3Z9661. This new...

ZEUS Scientific launches new landing page for the ANA Hybrid prototype assay
August 8th, 2012

Which method of ANA screening to use in clinical laboratories has been a matter of significant debate in many countries for several years now. Laboratories and physicians are divided between IFA,...

Dynex Technologies to Supply SmartKit™ ELISA Kit Packaging to ZEUS Scientific
June 1st, 2012

Chantilly, Virginia, Jan. 17, 2012 – Dynex Technologies announced today it has finalized a supply agreement with ZEUS Scientific Inc. (Branchburg, NJ), allowing ZEUS to utilize SmartKit™ packaging in...

ZEUS Scientific Launches A New Digital, Interactive, Antinuclear Antibody (ANA) HEp-2 Pattern Identification Guide
February 29th, 2012

Take the guide from your desktop to a number of mobile Apple devices ...

Gamma Therapeutics Signs ELISA Immunoassay Manufacturing Contract with New Jersey-Based ZEUS Scientific
January 30th, 2012

Gamma Therapeutics, Inc., an Oregon early stage biotechnology venture developing cardiovascular disease diagnostic tests, surgical therapy and military medicine solutions, announced today that it has...

ZEUS Scientific Announces FDA Clearance for ZEUS ELISA Cardiolipin IgG/IgM/IgA Test System
December 27th, 2011

Branchburg, NJ– December 27, 2011 – ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA Cardiolipin IgG/IgM/IgA Test...

ZEUS Scientific Announces FDA Clearance for ZEUS ELISA HSV gG-2 IgG Test System
May 27th, 2011

ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA HSV gG-2 IgG Test System (product number 9Z9781G). This new Test...

ZEUS Scientific Announces FDA Clearance for ZEUS ELISA HSV gG-1 IgG Test System
April 29th, 2011

ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA HSV gG-1 IgG Test System (product number 9Z9761G). This new Test...

ZEUS Scientific Announces FDA Clearance for ZEUS ELISA Treponema pallidum IgG Test System
March 3rd, 2011

ZEUS Scientific Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA Treponema pallidum IgG Plus Test System. This new Test System is...

ZEUS Scientific Announces CE Mark for AtheNA Multi-Lyte® MMRV IgG Test System
December 13th, 2010

ZEUS Scientific Inc. is pleased to announce it has obtained CE Marking for the AtheNA Multi-Lyte® MMRV IgG Plus Test System (catalog number A93101G). The results from this Test System are intended for...

ZEUS Scientific Announces FDA Clearance for AtheNA Multi-Lyte® Treponema pallidum IgG Test System
October 26th, 2010

ZEUS Scientific Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® Treponema pallidum IgG Plus Test System. This new Test System...

ZEUS Scientific Announces FDA Clearance for AtheNA Multi-Lyte® ToRCH IgG Test System
August 2nd, 2010

ZEUS Scientific, Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® ToRCH IgG Plus Test System. This new Test System is intended...

ZEUS Scientific Announces FDA Clearance for AtheNA Multi-Lyte® Borrelia Test System
July 16th, 2010

ZEUS Scientific, Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® Borrelia VlsE-1 IgG/pepC10 IgM Plus Test System. This new...

Zeus Scientific Expands Zeus ELISA Test System to include Treponema pallidum IgG for Syphilis
February 6th, 2010

ZEUS Scientific, Inc. is pleased to announce CE marking of the ZEUS ELISA Treponema pallidum (syphilis) IgG Test System. ...

Zeus Scientific to Offer a Rapid Nasal Screening Test for Methicillin-resistant Staphylococcus Aureus (MRSA)
July 3rd, 2008

ZEUS Scientific, Inc. today announced its intention to offer a rapid nasal screening test for methicillin-resistant Staphylococcus aureus (MRSA). The test is based upon ZEUS' own proprietary...

Zeus Scientific Announces AIMS® System that Enables Same Platform Processing for Both AtheNA Multi-Lyte® and ELISA
May 23rd, 2008

ZEUS Scientific, Inc. is pleased to announce the availability of the AIMS (Automated Immunoassay Multiplexing System) platform. ...